Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07767370
EARLY_PHASE1

ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea

Sponsor: The Second Hospital of Nanjing Medical University

View on ClinicalTrials.gov

Summary

This is a randomized controlled trial to explore the efficacy and safety of ND-12 combined with H-6 for patients with chronic inflammatory diarrhea

Official title: A Randomised, Controlled, Double-blind Exploratory Study of ND-12 Combined With H-6 in the Treatment of Adult Chronic Inflammatory Diarrhea

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2026-07-20

Completion Date

2028-08-31

Last Updated

2026-08-17

Healthy Volunteers

No

Interventions

DRUG

mesalazine

Take 4 melesalazine capsules each time, 3 times a day. Continue for 14 days.

DRUG

ND-12

Take 1 ND-12 capsule and 3 blank capsules each time, 3 times a day. Continue for 14 days

DRUG

ND-12/H-6

Take 1 ND-12 capsule and 3 H-6 capsules each time, 3 times a day. Continue for 14 days

Locations (1)

The Second Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China